News Focus
News Focus
icon url

Investor2014

02/10/22 9:31 AM

#350504 RE: boi568 #350501

Yes, analyst targets are always pegged to discounted future prospective revenue estimates. I think what I posted the other day below makes sense.

icon url

Gernee20

02/10/22 9:47 AM

#350514 RE: boi568 #350501

The Excellence trial timing didnt change, so how do you figure that it is the timing which impacted the lower target?
icon url

RedShoulder

02/10/22 10:50 AM

#350557 RE: boi568 #350501

Two cut price targets must have more to do with Rett EXCELLENCE trial timing than anything else, given the AVATAR results.



boi I agree. The need for the covid vaccinations before starting the Excellence trail has had a delayed effect (who saw that coming), in spite of the excellent Avatar results.
icon url

growingpain

02/10/22 11:40 AM

#350580 RE: boi568 #350501

Probably, it has to do with the biotech multiples shrinking over the past couple of months.